World Equity Group Inc. Sells 1,254 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

World Equity Group Inc. decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 60.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 816 shares of the healthcare conglomerate's stock after selling 1,254 shares during the period. World Equity Group Inc.'s holdings in UnitedHealth Group were worth $438,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of UNH. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $27,233,000. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG increased its stake in UnitedHealth Group by 3.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after acquiring an additional 9,872 shares during the period. Finally, Blackston Financial Advisory Group LLC lifted its position in shares of UnitedHealth Group by 12.8% during the 4th quarter. Blackston Financial Advisory Group LLC now owns 1,086 shares of the healthcare conglomerate's stock valued at $549,000 after acquiring an additional 123 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, Director John H. Noseworthy bought 300 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director now directly owns 6,063 shares in the company, valued at approximately $1,892,626.08. The trade was a 5.21% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Down 1.7%

Shares of UNH stock opened at $302.04 on Friday. The stock has a 50-day moving average of $359.15 and a 200-day moving average of $462.77. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market cap of $273.99 billion, a price-to-earnings ratio of 12.65, a PEG ratio of 1.42 and a beta of 0.44. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company earned $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Truist Financial reaffirmed a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Barclays dropped their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Finally, KeyCorp decreased their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $427.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.